CITIUS PHARMACEUTICALS INC (CTXR) Institutional Shareholders

CITIUS PHARMACEUTICALS INC (CTXR) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $822,404 in CTXR holdings during the latest filing period.

Geode Capital Management, Llc is currently the largest disclosed institutional shareholder of CTXR tracked by InsiderSet, reporting ownership valued at approximately $130,302 in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $124,709.708, representing an estimated loss of -4.29% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 82% of the total disclosed CTXR value among the investors covered in this analysis. Major shareholders include Geode Capital Management, Llc, Vanguard Capital Management Llc, Miller Financial Services Llc, and several other long-term asset managers with concentrated positions in CITIUS PHARMACEUTICALS INC (CTXR).

This page ranks the largest institutional CTXR shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

42

Total Reported Value

$822,404

Largest Holder

Geode Capital Management, Llc

Largest Position

$130,302

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

57

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Geode Capital Management, Llc0.00%215,537$130,302$124,710-$5,592-4.29%
Vanguard Capital Management Llc0.00%197,364$119,405$114,195-$5,210-4.36%
Miller Financial Services Llc0.06%130,000$78,585$75,218-$3,367-4.28%
Citadel Advisors Llc0.00%124,910$75,508$72,273-$3,235-4.28%
Jane Street Group, Llc0.00%122,837$74,255$71,073-$3,182-4.28%
Vanguard Fiduciary Trust Co0.00%77,755$47,042$44,989-$2,053-4.36%
Blackrock, Inc.0.00%69,850$42,224$40,415-$1,809-4.28%
Northern Trust Corp0.00%62,742$37,928$36,303-$1,625-4.29%
Xtx Topco Ltd0.00%59,199$35,786$34,253-$1,533-4.29%
Asset Advisory Group, Inc.0.02%59,011$35,672$34,144-$1,528-4.28%
Bostonpremier Wealth Llc0.01%28,000$16,926$16,201-$725-4.28%
Ubs Group Ag0.00%26,335$15,933$15,237-$696-4.37%
Lpl Financial Llc0.00%25,445$15,381$14,722-$659-4.28%
State Street Corp0.00%23,271$14,067$13,465-$602-4.28%
Virtu Financial Llc0.00%20,836$13,000$12,056-$944-7.26%
Arkadios Wealth Advisors0.00%20,000$12,090$11,572-$518-4.28%
Two Sigma Investments, Lp0.00%17,494$10,575$10,122-$453-4.28%
Sanctuary Advisors, Llc0.00%11,810$7,139$6,833-$306-4.28%
Susquehanna International Group, Llp0.00%11,795$7,130$6,825-$305-4.28%
R Squared Ltd0.00%11,033$6,670$6,384-$286-4.29%
Two Sigma Securities, Llc0.00%10,006$6,049$5,789-$260-4.29%
Sbi Securities Co., Ltd.0.00%9,519$5,754$5,508-$246-4.28%
Chelsea Counsel Co0.00%4,626$2,797$2,677-$120-4.30%
Quent Capital, Llc0.00%4,232$2,558$2,449-$109-4.28%
Ifp Advisors, Inc0.00%4,183$2,529$2,420-$109-4.30%
Tower Research Capital Llc (Trc)0.00%2,724$1,647$1,576-$71-4.30%
Osaic Holdings, Inc.0.00%2,575$1,543$1,490-$53-3.44%
Group One Trading Llc0.00%1,551$938$897-$41-4.33%
Simplex Trading, Llc0.00%1,256$759$727-$32-4.25%
Barclays Plc0.00%1,096$663$634-$29-4.35%
Wells Fargo & Company/Mn0.00%1,000$605$579-$26-4.36%
Luminist Capital Llc0.00%435$263$252-$11-4.30%
Assetmark, Inc0.00%372$225$215-$10-4.34%
Princeton Global Asset Management Llc0.00%160$97$93-$4-4.56%
Smallwood Wealth Investment Management, Llc0.00%120$72$69-$3-3.57%
Jpmorgan Chase & Co0.00%120$69$69+$0+0.63%
Bnp Paribas Financial Markets0.00%107$65$62-$3-4.75%
Arax Advisory Partners0.00%84$51$49-$2-4.70%
Federation Des Caisses Desjardins Du Quebec0.00%80$48$46-$2-3.57%
Morgan Stanley0.00%44$27$25-$2-5.71%
Fairscale Capital, Llc0.00%42$25$24-$1-2.80%
Bogart Wealth, Llc0.00%4$2$2+$0+15.72%
Showing 42 of 42

Frequently asked questions about CTXR

  • Who are the largest institutional holders of CTXR?

    The largest institutional holders of CTXR reported in the latest SEC Form 13F filings include Geode Capital Management, Llc, Vanguard Capital Management Llc, Miller Financial Services Llc, Citadel Advisors Llc, and Jane Street Group, Llc. InsiderSet ranks institutional holders by their latest reported CTXR position.

  • What is CTXR institutional ownership?

    This page tracks CTXR positions reported by institutional investment managers through SEC Form 13F. CITIUS PHARMACEUTICALS INC (CTXR) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own CTXR?

    InsiderSet currently tracks 42 institutional managers reporting CTXR holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of CTXR shareholders.

  • How much CTXR stock do institutions own?

    Institutional investment managers disclosed approximately $822,404 in CTXR holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was CTXR institutional ownership last updated?

    The latest CTXR institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional CTXR holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its CTXR position after the reporting date.

  • Are institutions buying or selling CTXR?

    Institutional buying and selling can be analyzed by comparing CTXR positions across consecutive 13F reporting periods. InsiderSet's CTXR Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View CTXR ownership changes.

  • How has CTXR institutional ownership changed over time?

    InsiderSet tracks CTXR institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.